Author

Fang Wu

ORCID 0000-0002-4194-2243Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Fang Wu7 papers · Emory University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chuyu Chen· 1 shared Gang Xiang· 1 shared Guiying Xu· 1 shared Jing YuiD· 1 shared Lei Zhang· 1 shared Lianbo Zhang· 1 shared Ling CheniD· 1 shared Shuxuan Wang· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chuyu Chen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivNov 15, 2023

A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.

Ling Chen, Guiying Xu, Xiaoxu Song…·Jing Yu

This study identifies verteporfin as a potent CCL5/CCR5 axis antagonist that suppresses TNBC tumor growth and metastasis through CCR5-YAP1 regulation.

DOI 10.1016/j.canlet.2024.216635

humanbulk RNA-seq

𝕏 PostBluesky